EVP, Global Head of R, D Martin Mackay sold $343K of Alexion Pharmaceuticals, Inc.

Sold$342,904

$125.70Price

2,728Shares

−6%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Mon, Feb 6. Filed Wed, Feb 8, 4:39 PM ET, after the close. Not investment advice.